ArticleEndocrine, metabolic & immune disorders drug targets2025

METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.

Chan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.